THMO
THERMOGENESIS HLDGS INC
stockOTC
thermogenesis holdings, inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (car)-t and other cell-based therapies. it markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed car-txpress platform, which streamlines the manufacturing process for the emerging car-t immunotherapy market. the company operates through two segments, device and clinical development. it manufactures and markets products for clinical bio-banking applications, including axp automated cell separation system, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and bioarchive automated cryopreservation system, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical appli
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 0.00 | 2026-09-08 | +9900.00% | 112639.167 |
| 1Y | 0.00 | 2025-10-24 | +9900.00% | -10.268 |
| 2Y | 0.00 | 2024-10-21 | -80.00% | — |
| 5Y | 80.55 | 2021-10-21 | -100.00% | 24.295 |
THERMOGENESIS HLDGS INC (OTC:THMO) stock price today is $0.00, and today's volume is 2,000. THMO is up 0.000% today. The 30 day average volume is 3,473. THMO market cap is $795 with 7.95M shares outstanding.